ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Moser, Christian, Lang, Sven A, Mori, Akira, Hellerbrand, Claus, Schlitt, Hans J, Geissler, Edward K, Fogler, William E and Stoeltzing, Oliver (2008) ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo. BMC Cancer 8 (1).Date of publication of this fulltext: 19 Dec 2024 13:15
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | BMC Cancer | ||||
| Publisher: | BMC | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 8 | ||||
| Number of Issue or Book Chapter: | 1 | ||||
| Date | 2008 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie Medicine > Lehrstuhl für Innere Medizin I | ||||
| Identification Number |
| ||||
| Keywords | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RANDOMIZED CONTROLLED TRIAL; FACTOR 1-ALPHA HIF-1-ALPHA; TUMOR-GROWTH; VEGF EXPRESSION; PANCREATIC-CANCER; MULTIPLE-MYELOMA; GENE-EXPRESSION; AUTOCRINE LOOP; BREAST-CANCER; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 67983 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric